UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inflammation and peripheral arterial disease: The value of circulating biomarkers (Review)

International journal of molecular medicine, 2014-04, Vol.33 (4), p.777-783

2014

Volltextzugriff (PDF)

Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response

Oncotarget, 2012-09, Vol.3 (9), p.954-987

2012

Volltextzugriff (PDF)

Calorie Restriction Modulates Inactivity-Induced Changes in the Inflammatory Markers C-Reactive Protein and Pentraxin-3

The journal of clinical endocrinology and metabolism, 2008-08, Vol.93 (8), p.3226-3229

2008

Volltextzugriff (PDF)

The involvement of the transcription factor Yin Yang 1 in cancer development and progression

Cell cycle (Georgetown, Tex.), 2009-05, Vol.8 (9), p.1367-1372

2009

Volltextzugriff (PDF)

Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression

Cell cycle (Georgetown, Tex.), 2010-02, Vol.9 (3), p.557-563

2010

Volltextzugriff (PDF)

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

Urolithiasis, 2005-02, Vol.33 (1), p.44-50

2005

Volltextzugriff (PDF)

Molecular targeted therapy in melanoma: a way to reverse resistance to conventional drugs

Current drug delivery, 2012-01, Vol.9 (1), p.17-29

2012

Volltextzugriff (PDF)

Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders

Cancer biology & therapy, 2005-11, Vol.4 (11), p.1192-1194

2005

Volltextzugriff (PDF)

FOXP3 expression is modulated by TGF-[beta]1/NOTCH1 pathway in human melanoma

International journal of molecular medicine, 2018-07, Vol.42 (1), p.392

2018

Volltextzugriff (PDF)

Absence of BRAF Gene Mutation in Non-Melanoma Skin Tumors

Cell cycle (Georgetown, Tex.), 2006-05, Vol.5 (9), p.968-970

2006

Volltextzugriff (PDF)

FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma

International journal of molecular medicine, 2018-07, Vol.42 (1), p.392-404

2018

Volltextzugriff (PDF)

Melanoma: Molecular pathogenesis and emerging target therapies (Review)

International journal of oncology, 2009-06, Vol.34 (6), p.1481-1489

2009

Volltextzugriff (PDF)

Abstract 4304: MMP-9 as a marker of response to treatment with B-Raf inhibitors in cutaneous melanoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4304-4304

2015

Volltextzugriff (PDF)

Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract

Pediatric research, 2004-04, Vol.55 (4), p.666-673

2004

Volltextzugriff (PDF)

Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines

Cytokine (Philadelphia, Pa.), 2011-11, Vol.56 (2), p.403-410

2011

Volltextzugriff (PDF)

Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas

Acta histochemica, 2013-10, Vol.115 (8), p.795-802

2013

Volltextzugriff (PDF)

Modulation of YY1 and p53 expression by transforming growth factor-[beta]3 in prostate cell lines

Cytokine (Philadelphia, Pa.), 2011-11, Vol.56 (2), p.403-410

2011

Volltextzugriff (PDF)

Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis

International journal of molecular medicine, 2013-05, Vol.31 (5), p.1011-1016

2013

Volltextzugriff (PDF)

Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland

Archives of oral biology, 2013-04, Vol.58 (4), p.370-376

2013

Volltextzugriff (PDF)

Abstract 5263: Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5263-5263

2011

Volltextzugriff (PDF)

Analysis of the [B-RAF.sup.V600E] mutation in cutaneous melanoma patients with occupational sun exposure

Oncology reports, 2014-03, Vol.31 (3), p.1079

2014

Volltextzugriff (PDF)

6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients

Cytokine (Philadelphia, Pa.), 2013, Vol.62 (1), p.64-69

2013

Volltextzugriff (PDF)

Inflammatory status in patients with chronic renal failure: The role of PTX3 and pro-inflammatory cytokines

International journal of molecular medicine, 2007-10, Vol.20 (4), p.471-481

2007

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)
Berichte
(3)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(22)
Cell Biology
(8)
Male
(8)
Female
(7)
Medicine, Research & Experimental
(7)
Oncology
(7)
Research & Experimental Medicine
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Melanoma
(6)
Proteins
(6)
Animals
(5)
Cytokines
(5)
Signal Transduction
(5)
Targeted Therapy
(5)
Antineoplastic Agents - Therapeutic Use
(4)
Cancer
(4)
Cell Line, Tumor
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inflammation and peripheral arterial disease: The value of circulating biomarkers (Review)

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance

Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response

Calorie Restriction Modulates Inactivity-Induced Changes in the Inflammatory Markers C-Reactive Protein and Pentraxin-3

The involvement of the transcription factor Yin Yang 1 in cancer development and progression

Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

Molecular targeted therapy in melanoma: a way to reverse resistance to conventional drugs

Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders

FOXP3 expression is modulated by TGF-[beta]1/NOTCH1 pathway in human melanoma

Absence of BRAF Gene Mutation in Non-Melanoma Skin Tumors

FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma

Melanoma: Molecular pathogenesis and emerging target therapies (Review)

Abstract 4304: MMP-9 as a marker of response to treatment with B-Raf inhibitors in cutaneous melanoma

Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract

Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines

Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas

Modulation of YY1 and p53 expression by transforming growth factor-[beta]3 in prostate cell lines

Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis

Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland

Abstract 5263: Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer

Advances in targeting signal transduction pathways

Analysis of the [B-RAF.sup.V600E] mutation in cutaneous melanoma patients with occupational sun exposure

6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients

Inflammatory status in patients with chronic renal failure: The role of PTX3 and pro-inflammatory cytokines

Aktive Filter

Suchergebnisse filtern